Latest drug development News

Antibiotic resistance is a growing problem, but solutions do exist – expert Q&A
AI Research Team Could Streamline Clinical Trial Design
Largest study yet reveals which cancers have their own microbiomes
New way to ‘listen’ to mini hearts could transform drug development
PolyU showcases life sciences and healthcare innovations at BIO International Convention 2026
Using AI To Tackle Global Superbug Crisis
Promising prostate cancer therapy accelerated for patients with ‘urgent unmet needs’
Shifting Dial In Myelodysplastic Syndromes Treatment
Pär Nordlund awarded the Prize for Innovation and Utilization 2026
New biological insights into progressive multiple sclerosis identified in a recent study
MHF commits landmark $18.9m boost to accelerate brain cancer research
Three KI Projects On 2026 IVA Research Impact List
We Stand With Daniher Family To Defeat Beast
Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease
Victorian Premier Issues Statement 25 May
Research Project Promoting Patient-Specific Nucleic Acid Drug Development for Rare and Intractable Diseases (N-of-1+ Drug Development) Selected by AMED
Entropy gives a ‘marriage’ of molecules just enough freedom
‘Atomic snapshots’ of proofreading enzyme could lead to better COVID-19 drugs
HKUST Team Unveils Innovative Technology for Precise Reading and Control of Brain Circuits to Advance Brain Disease Research
Drug developer acquires potential cancer treatment discovered by QIMR Berghofer researcher
AI is reengineering drug discovery by speeding up testing and scanning petabytes of data for connections between diseases
Australian Academy of Science recognises pioneering infectious disease researcher
HKUST Researchers Develop Pioneering Organocatalytic Strategy for Chiral Sulfinamides with Antiviral Potential
KIFFIK Biomedical and HekaBio Announce Strategic Alliance to Expand ISF-Based Molecular Access Across Asia-Pacific
Hanna Brauner: “We’ve had a frank and sincere discussion climate”
HKUST Launches NeuroCare Community Project to Screen 6,000 Elderly for Early Alzheimer’s
Funding for Australian-first alliance boosting access to life-saving clinical cancer trials
NSW new funding for Australian-first alliance boosting access to life-saving clinical cancer trials
Australian consortium to develop quantum biotechnology platform to transform Alzheimer’s treatment discovery
New antibody-drug conjugate strategy to block HIV infection
How Studying Yeast in the Gut Could Lead to New, Better Drugs
Why is US health care still the most expensive in the world after decades of cost-cutting initiatives?
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution
A disease caused by the loss of “a guardian of kidney health”
New tool exposes scale of fake research flooding cancer science
MPG Spin-off QLi5 receives Multi-million Euro Investment from Qurient Therapeutics
Bill Gates Visits KI’s Alzheimer’s Researchers
Hope For Smarter Lung Cancer Care
Four innovation grants awarded to KI by the Knut and Alice Wallenberg Foundation
Australian start-up unveils world-first physics model to visualise human proteins
Heart hope as potential funnel-web venom drug enters clinical trial
Revealing the Mechanism Behind Quality Control of Insulin in the Endoplasmic Reticulum
Cancer And Allergy Fund Supports Cancer Research At KI
The Swedish Cancer and Allergy Fund supports cancer research at KI
Patient-specific Human Liver Model
New antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission
Toward Better Life Guided By Mental Wellbeing
AI tool creates ‘digital twins’ of patients to predict their future health